Involvement of IL‐6/JAK/STAT3/SOCS3, SIRT1, and Cytoglobin Signaling in Diacerein Protective Effect against Intestinal Injury Induced by Methotrexate
Journal of Biochemical and Molecular Toxicology · 2025-06 · 39 (6)
DOI: 10.1002/jbt.70339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 09.06.2025. Verfasst von Gaber F Ali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Hauptthemen laut MEDLINE: Methotrexate, Suppressor of Cytokine Signaling 3 Protein, Sirtuin 1, Interleukin-6. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: Deanship of Scientific Research at Shaqra University.
Abstract (Originalsprache)
Despite its wide applications, methotrexate (MTX) causes significant intestinal toxicity by inducing oxidative stress, inflammatory cascades, and apoptosis. Diacerein (DIA) is a pain‐relieving and anti‐inflammatory medication with favorable antioxidant properties. We investigated DIA protective effects on MTX‐induced intestinal toxicity. Rats were divided into five groups: Control, DIA (50 mg/kg), MTX (single dose of 20 mg/kg; i.p. on 5th day), DIA (25 mg/kg) + MTX, and DIA (50 mg/kg) + MTX. Compared to the MTX‐treated group, DIA alleviated MTX‐induced intestinal histopathological abrasions and inflammatory cell infiltration, improving average villous length and crypt depth. Furthermore, DIA exhibited potent antioxidative properties, evident by decreasing lipid peroxidation and increasing SOD activity and GSH content, and upregulating the expression of SIRT1 and cytoglobin. In addition, DIA ameliorated MTX‐induced intestinal inflammation demonstrated by decreasing IL‐6 and TNF‐α mediated via suppressing NF‐κBp65, phosphorylation of JAK1/STAT3, and upregulation of SOCS3 expression compared to the MTX‐treated group. Furthermore, DIA inhibited intestinal apoptotic alterations by reducing cleaved caspase‐3 protein expression. These results suggest that DIA, in a dose‐dependent manner, could be an effective treatment for reducing intestinal toxicity by MTX via exerting an antioxidant effect, anti‐inflammatory properties, and antiapoptotic activity with possible involvement of NF‐κBp65, IL‐6/JAK1/STAT3/SOCS3, SIRT1, and cytoglobin signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
- Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.
- Department of Pharmacology, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia.
- Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.
- Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
ORCID-Profile: El-Shaimaa A Arafa
Förderung
- Deanship of Scientific Research at Shaqra University
Zitieren
APA
Ali, G. F., Hassanein, E. H. M., Abdel-Reheim, M. A., Arafa, E. A., & Mohamed, W. R. (2025). Involvement of IL‐6/JAK/STAT3/SOCS3, SIRT1, and Cytoglobin Signaling in Diacerein Protective Effect against Intestinal Injury Induced by Methotrexate. Journal of Biochemical and Molecular Toxicology, 39(6). https://doi.org/10.1002/jbt.70339
Vancouver
Ali GF, Hassanein EHM, Abdel-Reheim MA, Arafa EA, Mohamed WR. Involvement of IL‐6/JAK/STAT3/SOCS3, SIRT1, and Cytoglobin Signaling in Diacerein Protective Effect against Intestinal Injury Induced by Methotrexate. Journal of Biochemical and Molecular Toxicology. 2025;39(6). doi:10.1002/jbt.70339
BibTeX
@article{Ali2025,
author = {Ali, Gaber F and Hassanein, Emad H M and Abdel-Reheim, Mustafa Ahmed and Arafa, El-Shaimaa A and Mohamed, Wafaa R},
title = {Involvement of IL‐6/JAK/STAT3/SOCS3, SIRT1, and Cytoglobin Signaling in Diacerein Protective Effect against Intestinal Injury Induced by Methotrexate},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
volume = {39},
number = {6},
doi = {10.1002/jbt.70339}
}
EUVIMED